CDK4/6 inhibition provides additional efficacy in HER2+, HR+ breast cancer

Nature Reviews Clinical Oncology 2026

View at publisher

Authors: David Killock

DOI: 10.1038/s41571-026-01133-2

Cited by: 0

References: 1

Fields of Study & Subjects

Advanced Breast Cancer Therapies Breast Cancer Treatment Studies PARP inhibition in cancer therapy

References 1